Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

被引:22
作者
Argiro, L [1 ]
Henri, S [1 ]
Dessein, H [1 ]
Dessein, AJ [1 ]
Bourgois, A [1 ]
机构
[1] Univ Mediterranee, Fac Med, Lab Immunol & Genet Parasit Dis, INSERM,U399, F-13385 Marseille 5, France
关键词
Schistosomiasis; vaccination; cytokine;
D O I
10.1016/S0264-410X(98)00152-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A previous study has shown that Sm37-5 is a major B cell epitope of Sm37-GAPDH. This epitope is highly antigenic in human infections and IgG antibody reactivity toward this determinant is associated with adolescent resistance to reinfection. This led us to test a synthetic peptide corresponding to Sm37-5, coupled to ovalbumin, as an anti-schistosome vaccine. Although mice injected with Sm37-5-OVA in Freund's adjuvant showed significant protection, immunization in aluminium hydroxide failed to induce protection. The adjuvant effect of cytokines (GM-CSF or IL-12) associated with the antigen on alum was investigated. With each of these two cytokines, significant reductions in the worm burden were obtained (32-38% with GM-CSF and 27% with IL-12, respectively). In addition, a reduction of the egg number trapped in the liver of immunized mice was also observed. Thus, protections were obtained with formulations that could potentially be used in humans. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 23 条
[11]   GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-1 MEDIATE THE MATURATION OF MURINE EPIDERMAL LANGERHANS CELLS INTO POTENT IMMUNOSTIMULATORY DENDRITIC CELLS [J].
HEUFLER, C ;
KOCH, F ;
SCHULER, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :700-705
[12]   Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms [J].
Metzger, DW ;
McNutt, RM ;
Collins, JT ;
Buchanan, JM ;
VanCleave, VH ;
Dunnick, WA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1958-1965
[13]  
MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113
[14]  
PARDOLL DM, 1995, ANNU REV IMMUNOL, V13, P399, DOI 10.1146/annurev.immunol.13.1.399
[15]   STRONG SERUM INHIBITION OF SPECIFIC IGE CORRELATED TO COMPETING IGG4, REVEALED BY A NEW METHODOLOGY IN SUBJECTS FROM A SCHISTOSOMA-MANSONI ENDEMIC AREA [J].
RIHET, P ;
DEMEURE, CE ;
DESSEIN, AJ ;
BOURGOIS, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2063-2070
[16]   IL-12 - INITIATION CYTOKINE FOR CELL-MEDIATED-IMMUNITY [J].
SCOTT, P .
SCIENCE, 1993, 260 (5107) :496-497
[17]  
SMITH PD, 1990, J IMMUNOL, V144, P3829
[18]   INFECTION OF LABORATORY HOSTS WITH CERCARIAE OF SCHISTOSOMA MANSONI AND RECOVERY OF ADULT WORMS [J].
SMITHERS, SR ;
TERRY, RJ .
PARASITOLOGY, 1965, 55 :695-&
[19]   IDIOTYPE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FUSION PROTEIN AS A VACCINE FOR B-CELL LYMPHOMA [J].
TAO, MH ;
LEVY, R .
NATURE, 1993, 362 (6422) :755-758
[20]   Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM CSF) and a single dose of recombinant hepatitis B vaccine [J].
Tarr, PE ;
Lin, R ;
Mueller, EA ;
Kovarik, JM ;
Guillaume, M ;
Jones, TC .
VACCINE, 1996, 14 (13) :1199-1204